SALTON, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 2.370
NA - Nord America 2.280
AS - Asia 1.014
AF - Africa 31
OC - Oceania 16
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.729
Nazione #
US - Stati Uniti d'America 2.226
IT - Italia 790
PL - Polonia 689
HK - Hong Kong 296
SE - Svezia 282
CN - Cina 248
SG - Singapore 242
DE - Germania 114
BG - Bulgaria 84
GB - Regno Unito 65
FI - Finlandia 64
IE - Irlanda 64
VN - Vietnam 51
CH - Svizzera 47
IN - India 37
MX - Messico 33
KR - Corea 31
FR - Francia 30
TR - Turchia 28
BE - Belgio 26
TW - Taiwan 25
ES - Italia 20
CA - Canada 19
NL - Olanda 17
RU - Federazione Russa 16
SN - Senegal 16
UA - Ucraina 16
JP - Giappone 15
AU - Australia 14
PT - Portogallo 11
EG - Egitto 9
IR - Iran 9
AT - Austria 8
DK - Danimarca 7
PK - Pakistan 7
BR - Brasile 6
CZ - Repubblica Ceca 6
GR - Grecia 6
SA - Arabia Saudita 5
CL - Cile 4
ID - Indonesia 4
RO - Romania 4
TH - Thailandia 4
CO - Colombia 3
EU - Europa 3
KZ - Kazakistan 3
YE - Yemen 3
AR - Argentina 2
CI - Costa d'Avorio 2
IL - Israele 2
NZ - Nuova Zelanda 2
PH - Filippine 2
ZA - Sudafrica 2
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
ET - Etiopia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MY - Malesia 1
PR - Porto Rico 1
Totale 5.729
Città #
Warsaw 686
Chandler 440
Hong Kong 283
Trieste 189
Singapore 175
Ashburn 159
Fairfield 157
Princeton 94
Beijing 91
Seattle 86
Woodbridge 85
Sofia 83
Wilmington 81
Houston 69
Ann Arbor 66
Boardman 55
Dublin 53
Dong Ket 49
Redmond 45
Milan 43
Cambridge 42
Helsinki 33
Bern 31
Santa Clara 31
Jacksonville 30
Lappeenranta 29
Los Angeles 28
Seoul 28
Columbus 26
Rome 24
Redwood City 23
Bremen 22
Falls Church 19
Shanghai 18
Brussels 16
Dakar 16
Boydton 15
Guangzhou 15
Grafing 14
Izmir 14
Arzene 13
Udine 13
Pune 12
San Diego 11
Taipei 11
Cividale del Friuli 10
Fagagna 10
London 10
Tappahannock 10
Torre Del Greco 10
Washington 10
Barcelona 9
Dallas 9
Obregon 9
Venezia 9
Centro 8
Sydney 8
West Jordan 8
Central 7
Duino-Aurisina 7
Manchester 7
Somerville 7
Vienna 7
Brescia 6
Council Bluffs 6
Des Moines 6
Ghent 6
Jinan 6
Lisbon 6
Menomonie 6
Monfalcone 6
Padova 6
Phoenix 6
San Donà di Piave 6
Tokyo 6
Verona 6
Birmingham 5
Hebei 5
Naples 5
Norwalk 5
Paris 5
Philadelphia 5
Saint Louis 5
Toronto 5
Treviso 5
Turin 5
Berlin 4
Bologna 4
Brno 4
Calcinato 4
Cankaya 4
Cardiff 4
Chicago 4
Fuzhou 4
Genoa 4
Giugliano in Campania 4
Hefei 4
Jakarta 4
Madrid 4
Marano Di Napoli 4
Totale 3.862
Nome #
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 374
Acute respiratory distress syndrome 316
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 264
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 251
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 228
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 214
Imaging review of the lung parenchymal complications in patients with IPF 153
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 146
Alveolar Epithelial Type II Cells 134
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 119
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 113
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 107
The Treatment of Lung Involvement in Systemic Sclerosis 98
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 97
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 97
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 96
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 95
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 88
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 86
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 84
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 84
Chronic Thromboembolic Pulmonary Hypertension: An Update 84
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 82
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 79
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 77
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 71
Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19 69
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 67
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 65
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 64
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 62
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 62
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 61
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 60
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 59
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 57
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 55
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 55
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 53
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 53
Caution When Comparing the Impact of Corticosteroids in COVID-19 53
Interstitial lung disease at high resolution ct after SARS‐COV‐2‐related acute respiratory distress syndrome according to pulmonary segmental anatomy 53
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 51
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 50
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 50
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study 50
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations 50
Pulmonary Fibrosis: one manifestation, various diseases 49
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 47
MicroRNA-200 revertono il fenotipo di pneumociti tipo II primari da fibrosi polmonare idiopatica 47
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 47
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 44
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 41
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 41
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 40
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update 40
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 38
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 38
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 37
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 35
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 35
The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis 34
Pulmonary fibrosis: one manifestation, various diseases 33
Low Arousal Threshold Estimation Predicts Failure of Mandibular Advancement Devices in Obstructive Sleep Apnea Syndrome 33
Host-Based Treatments for Severe COVID-19 32
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 32
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients 31
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 31
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 30
Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma 29
Editorial: Obstructive sleep apnea syndrome (OSAS). What's new? 28
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study 28
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 25
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS). WHAT’S NEW? 24
Monitoraggio degli scambi gassosi e dell’equilibrio acido-base durante ventilazione meccanica 23
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 23
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 22
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 22
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 22
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 22
Biomarkers in Systemic Sclerosis: An Overview 20
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 20
Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis 19
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 18
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 18
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 18
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 16
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 14
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 12
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 11
Evaluation of possible risk factor of pulmonary embolism in sarcoidosis patients 9
Totale 6.114
Categoria #
all - tutte 22.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020555 0 0 33 82 45 69 74 55 70 55 37 35
2020/2021755 40 48 42 104 70 85 76 61 50 109 30 40
2021/2022885 55 39 69 72 58 52 100 23 126 60 56 175
2022/20231.526 135 204 154 178 115 198 48 133 188 30 105 38
2023/20241.526 92 79 117 107 129 149 304 210 47 82 136 74
2024/2025395 74 178 143 0 0 0 0 0 0 0 0 0
Totale 6.114